{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:09:45Z","timestamp":1775027385250,"version":"3.50.1"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.2967\/jnumed.119.227793","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T23:35:15Z","timestamp":1566862515000},"page":"183-188","source":"Crossref","is-referenced-by-count":33,"title":["Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18<\/sup>F-DCFPyL Versus Na<sup>18<\/sup>F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer"],"prefix":"10.2967","volume":"61","author":[{"given":"Steven P.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Trock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"DiGianvittorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Keith","family":"Bleiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane K.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Pienta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"2021051712142893000_61.2.183.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21442"},{"key":"2021051712142893000_61.2.183.2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of the site of metastases on survival in patients with metastatic prostate cancer","volume":"68","author":"Gandaglia","year":"2015","journal-title":"Eur Urol."},{"key":"2021051712142893000_61.2.183.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.163782"},{"key":"2021051712142893000_61.2.183.4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41391-017-0007-8","article-title":"The use of PET\/CT in prostate cancer","volume":"21","author":"Li","year":"2018","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"2021051712142893000_61.2.183.5","first-page":"6357","article-title":"Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer","volume":"9","author":"Ross","year":"2003","journal-title":"Clin Cancer Res."},{"key":"2021051712142893000_61.2.183.6","first-page":"715","article-title":"Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia","volume":"19","author":"Marchal","year":"2004","journal-title":"Histol Histopathol."},{"key":"2021051712142893000_61.2.183.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.11.012"},{"key":"2021051712142893000_61.2.183.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.104661"},{"key":"2021051712142893000_61.2.183.9","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2021051712142893000_61.2.183.10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712142893000_61.2.183.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2298-2"},{"key":"2021051712142893000_61.2.183.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161299"},{"key":"2021051712142893000_61.2.183.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2012.06.034"},{"key":"2021051712142893000_61.2.183.14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bju.13435","article-title":"PSMA-targeted imaging of prostate cancer: the best is yet to come","volume":"117","author":"Gorin","year":"2016","journal-title":"BJU Int."},{"key":"2021051712142893000_61.2.183.15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11307-016-0957-6","article-title":"PSMA-based [18F]DCFPyL PET\/CT is superior to conventional imaging for lesion detection in patients with metastatic prostate cancer","volume":"18","author":"Rowe","year":"2016","journal-title":"Mol Imaging Biol."},{"key":"2021051712142893000_61.2.183.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.09.011"},{"key":"2021051712142893000_61.2.183.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.195255"},{"key":"2021051712142893000_61.2.183.18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2017.10.027","article-title":"PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies","volume":"73","author":"Rowe","year":"2018","journal-title":"Eur Urol."},{"key":"2021051712142893000_61.2.183.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.217653"},{"key":"2021051712142893000_61.2.183.20","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2967\/jnumed.118.217588","article-title":"Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on 18F-DCFPyL PET\/CT imaging","volume":"59","author":"Werner","year":"2018","journal-title":"J Nucl Med."},{"key":"2021051712142893000_61.2.183.21","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf215"},{"key":"2021051712142893000_61.2.183.22","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00259-018-4058-4","article-title":"Prospective comparison of 68Ga-PSMA PET\/CT, 18F-sodium fluoride PET\/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer","volume":"45","author":"Zacho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712142893000_61.2.183.23","doi-asserted-by":"crossref","unstructured":"Dyrberg E Hendel HW Huynh THV . 68Ga-PSMA-PET\/CT in comparison with 18F-fluoride-PET\/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study. Eur Radiol. 2019;29:1221\u20131230.","DOI":"10.1007\/s00330-018-5682-x"},{"key":"2021051712142893000_61.2.183.24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2967\/jnumed.117.207373","article-title":"A prospective comparison of 18F-sodium fluoride PET\/CT and PSMA-targeted 18F-DCFBC PET\/CT in metastatic prostate cancer","volume":"59","author":"Harmon","year":"2018","journal-title":"J Nucl Med."},{"key":"2021051712142893000_61.2.183.25","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00259-018-4048-6","article-title":"Comparison of [68Ga]Ga-PSMA-11 PET\/CT with [18F]NaF PET\/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy","volume":"45","author":"Uprimny","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712142893000_61.2.183.26","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.clgc.2016.09.002","article-title":"Correlation of PSMA-targeted 18F-DCFPyL PET\/CT findings with immunohistochemical and genomic data in a patient with metastatic neuroendocrine prostate cancer","volume":"15","author":"Tosoian","year":"2017","journal-title":"Clin Genitourin Cancer."},{"key":"2021051712142893000_61.2.183.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.203570"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.227793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:47:08Z","timestamp":1621284428000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.227793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,3]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.2967\/jnumed.119.227793"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.227793","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]}}}